Sean Mcgarry

Array ( [id] => 5558909 [patent_doc_number] => 20090270486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/341442 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13032 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270486.pdf [firstpage_image] =>[orig_patent_app_number] => 12341442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282921 [patent_doc_number] => 08217017 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Modulation of insulin like growth factor I receptor expression' [patent_app_type] => utility [patent_app_number] => 12/342025 [patent_app_country] => US [patent_app_date] => 2008-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 32167 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12342025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403458 [patent_doc_number] => 20090238772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR PREVENTION OR TREATMENT OF RSV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/335467 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 34641 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20090238772.pdf [firstpage_image] =>[orig_patent_app_number] => 12335467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496476 [patent_doc_number] => 20090264504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/334181 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 69973 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264504.pdf [firstpage_image] =>[orig_patent_app_number] => 12334181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570395 [patent_doc_number] => 20090253773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/334197 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 66091 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253773.pdf [firstpage_image] =>[orig_patent_app_number] => 12334197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570396 [patent_doc_number] => 20090253774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/334224 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 68148 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253774.pdf [firstpage_image] =>[orig_patent_app_number] => 12334224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546665 [patent_doc_number] => 20090156542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'MCP-1 Binding Nucleic Acids And Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/325180 [patent_app_country] => US [patent_app_date] => 2008-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 64 [patent_no_of_words] => 50272 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 61 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156542.pdf [firstpage_image] =>[orig_patent_app_number] => 12325180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4432109 [patent_doc_number] => 07968525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-06-28 [patent_title] => 'Use of RNA interference to validate new termiticide target sites and a method of termite control' [patent_app_type] => utility [patent_app_number] => 12/324312 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 56 [patent_no_of_words] => 9599 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968525.pdf [firstpage_image] =>[orig_patent_app_number] => 12324312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509095 [patent_doc_number] => 20090082302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'MODULATION OF EIF4E-BP2 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/274030 [patent_app_country] => US [patent_app_date] => 2008-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23995 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082302.pdf [firstpage_image] =>[orig_patent_app_number] => 12274030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725540 [patent_doc_number] => 08404657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx)' [patent_app_type] => utility [patent_app_number] => 12/744802 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5297 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12744802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564663 [patent_doc_number] => 20090137516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'COMPOSITIONS AND METHODS OF TREATING DYSLIPIDEMIA' [patent_app_type] => utility [patent_app_number] => 12/263591 [patent_app_country] => US [patent_app_date] => 2008-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7166 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137516.pdf [firstpage_image] =>[orig_patent_app_number] => 12263591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5575467 [patent_doc_number] => 20090142829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Recombinant Constructs And Their Use In Reducing Gene Expression' [patent_app_type] => utility [patent_app_number] => 12/256721 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23218 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142829.pdf [firstpage_image] =>[orig_patent_app_number] => 12256721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4499611 [patent_doc_number] => 07919311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'Compositions and methods for activating genes of interest' [patent_app_type] => utility [patent_app_number] => 12/254206 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6778 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919311.pdf [firstpage_image] =>[orig_patent_app_number] => 12254206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502749 [patent_doc_number] => 20090163437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'STEADY-STATE SUBCUTANEOUS ADMINISTRATION OF APTAMERS' [patent_app_type] => utility [patent_app_number] => 12/252994 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16848 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163437.pdf [firstpage_image] =>[orig_patent_app_number] => 12252994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256521 [patent_doc_number] => 07576196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'siRNA targeting transducin (beta)-like 3 (TBL3)' [patent_app_type] => utility [patent_app_number] => 12/287757 [patent_app_country] => US [patent_app_date] => 2008-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/576/07576196.pdf [firstpage_image] =>[orig_patent_app_number] => 12287757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316567 [patent_doc_number] => 20090281165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/287274 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15265 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281165.pdf [firstpage_image] =>[orig_patent_app_number] => 12287274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968645 [patent_doc_number] => 08507456 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'C5a binding nucleic acids' [patent_app_type] => utility [patent_app_number] => 12/679307 [patent_app_country] => US [patent_app_date] => 2008-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 38955 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12679307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4523912 [patent_doc_number] => 07951785 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'NFIA in glial fate determination, glioma therapy and astrocytoma treatment' [patent_app_type] => utility [patent_app_number] => 12/234366 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13385 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951785.pdf [firstpage_image] =>[orig_patent_app_number] => 12234366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195541 [patent_doc_number] => 20110027295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Adenosine Receptor Agonists and Antagonists to Modulate T Cell Responses' [patent_app_type] => utility [patent_app_number] => 12/676741 [patent_app_country] => US [patent_app_date] => 2008-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 30647 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027295.pdf [firstpage_image] =>[orig_patent_app_number] => 12676741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4434004 [patent_doc_number] => 07897753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'RNA interference mediated inhibition of XIAP gene expression using short interfering nucleic acid (siNA)' [patent_app_type] => utility [patent_app_number] => 12/205113 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 65446 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897753.pdf [firstpage_image] =>[orig_patent_app_number] => 12205113 [rel_patent_id] =>[rel_patent_doc_number] =>)